Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Taira, Naruto"" wg kryterium: Autor


Tytuł :
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
Autorzy :
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .
Kashiwabara K; Clinical Research Promotion Center, University of Tokyo Hospital, Tokyo, Japan.
Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
Kitada M; Breast Disease Center, Asahikawa Medical University Hospital, Hokkaido, Japan.
Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
Kato H; Department of Breast Surgery, Teine Keijinkai Hospital, Hokkaido, Japan.
Kikawa Y; Department of Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.
Sakata E; Department of Breast Surgery, Niigata City General Hospital, Niigata, Japan.
Naito Y; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Aomori, Japan.
Saito T; Department of Breast Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Iwasa T; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.
Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Aihara T; Breast Center, Aihara Hospital, Osaka, Japan.
Mukai H; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
Hara F; Breast Oncology Center, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2021 Sep 07. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry.
Autorzy :
Yamada A; Department of Gastroenterological Surgery Yokohama, City University Graduate School of Medicine, Yokohama, Japan. Electronic address: .
Kumamaru H; Department of Healthcare Quality Assessment, University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address: .
Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: .
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. Electronic address: .
Nakayama K; Department of Breast Surgery, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: .
Miyashita M; Department of Gerontological and Oncology Nursing, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: .
Honma N; Department of Pathology, Toho University School of Medicine, Tokyo, Japan. Electronic address: .
Miyata H; Department of Healthcare Quality Assessment, University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address: .
Endo I; Department of Gastroenterological Surgery Yokohama, City University Graduate School of Medicine, Yokohama, Japan. Electronic address: .
Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan. Electronic address: .
Sawaki M; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Sep; Vol. 154, pp. 157-166. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial.
Autorzy :
Hagiwara Y; Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Kawahara T; Biostatistics Division, Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Takahashi M; Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 188 (3), pp. 675-683. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Cognition ; Female ; Humans ; Neoplasm Staging ; Receptor, ErbB-2/genetics ; Trastuzumab/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.
Autorzy :
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Kawashima H; Department of Surgery, Aomori City Hospital, Aomori, Japan.
Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Sagawa N; Department of Breast Surgery, Kameda Medical Center, Kamogawa, Japan.
Bando H; Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takahashi M; Department of Breast Surgery, NHO Hokkaido Cancer Center, Sapporo, Japan.
Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan.
Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
Kashiwaba M; Department of Breast Surgery, Adachi Breast Clinic, Kyoto, Japan.
Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kawahara T; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
Pokaż więcej
Corporate Authors :
RESPECT Study Group
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Aug 01; Vol. 39 (22), pp. 2452-2462. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Autorzy :
Takabatake D; Kochi Health Science Center.
Kajiwara Y; Okayama University Hospital.
Ohtani S; Hiroshima Citizens Hospital.
Suzuki Y; Okayama University Hospital.
Yamamoto M; Fukuyama Citizens Hospital.
Kubo S; Fukuyama Citizens Hospital.
Ikeda M; Fukuyama Citizens Hospital.
Takahashi M; Shikoku Cancer Center.
Hara F; Cancer Institute Hospital.
Aogi K; Shikoku Cancer Center.
Ohsumi S; Shikoku Cancer Center.
Ogasawara Y; Kagawa Prefectural Center Hospital.
Nishiyama Y; Okayama Saiseikai General Hospital.
Hikino H; Matsue Red Cross General Hospital.
Matsuoka K; Ehime Prefectural Central Hospital.
Shien T; Okayama University Hospital.
Taira N; Okayama University Hospital.
Doihara H; Okayama University Hospital.
Pokaż więcej
Źródło :
Acta medica Okayama [Acta Med Okayama] 2021 Jun; Vol. 75 (3), pp. 357-362.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients' Health Status in Greater Detail?
Autorzy :
Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Saitama, Japan.
Hagiwara Y; Department of Biostatistics, Division of Health Sciences and Nursing, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Taira N; Breast and Endocrine Surgery Department, Okayama University Hospital, Okayama, Japan.
Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Bunkyo-ku, Japan.
Konomura K; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Saitama, Japan.
Iwamoto T; Department of Biostatistics, Division of Health Sciences and Nursing, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Noto S; Department of Rehabilitation, Niigata University of Health and Welfare, Niigata, Japan.
Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Saitama, Japan.
Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
Pokaż więcej
Źródło :
Medical decision making : an international journal of the Society for Medical Decision Making [Med Decis Making] 2021 Apr 24, pp. 272989X211010171. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Multicenter Study of Docetaxel at a Dose of 100 mg/m in Japanese Patients with Advanced or Recurrent Breast Cancer.
Autorzy :
Hirata T; Department of Medical Oncology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.
Ozaki S; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan.
Tabata M; Departments of Allergy and Respiratory Medicine, Okayama University Hospital, Japan.
Iwamoto T; Departments of Breast and Endocrine Surgery, Okayama University Hospital, Japan.
Hinotsu S; Department of Biostatistics, Sapporo Medical University, Japan.
Hamada A; Division of Clinical Pharmacology & Translational Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Japan.
Motoki T; Department of Surgery, Okayama Saiseikai General Hospital, Japan.
Nogami T; Department of Surgery, Tsuyama Chuo Hospital, Japan.
Shien T; Departments of Breast and Endocrine Surgery, Okayama University Hospital, Japan.
Taira N; Departments of Breast and Endocrine Surgery, Okayama University Hospital, Japan.
Matsuoka J; Departments of Breast and Endocrine Surgery, Okayama University Hospital, Japan.
Doihara H; Departments of Breast and Endocrine Surgery, Okayama University Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Apr 15; Vol. 60 (8), pp. 1183-1190. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Breast Neoplasms*/drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Docetaxel/therapeutic use ; Drug Administration Schedule ; Humans ; Japan/epidemiology ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Taxoids/therapeutic use
Czasopismo naukowe
Tytuł :
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study.
Autorzy :
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan. Electronic address: .
Sakamaki K; Department of Biostatistics, Yokohama City University, Yokohama, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Nishimura H; Department of Breast Surgery, Nagano Municipal Hospital, Nagano, Japan.
Sangai T; Department of Breast and Thyroid Surgery, Chiba University, Chiba, Japan.
Tamaki K; Naha-Nishi Clinic, Okinawa, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Aomori, Japan.
Watanabe KI; Department of Breast Surgery, Hokkaido Cancer Center, Hokkaido, Japan.
Suganuma N; Department of Breast and Thyroid Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
Michishita S; Department of Breast Surgery, Yao Municipal Hospital, Osaka, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Aihara T; Breast Center, Aihara Hospital, Osaka, Japan.
Tsugawa K; Department of Breast and Thyroid Surgery, St. Marianna University, Kawasaki, Japan.
Kaise H; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan.
Taira N; Department of Breast and Endocrinology Surgery, Okayama University Graduate School of Medicine, Okayama, Japan.
Mukai H; Division of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan.
Pokaż więcej
Corporate Authors :
for Comprehensive Support Project for Oncological Research of Breast Cancer
Źródło :
Breast (Edinburgh, Scotland) [Breast] 2021 Apr; Vol. 56, pp. 70-77. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Breast Neoplasms/*drug therapy
Febrile Neutropenia/*chemically induced
Neoadjuvant Therapy/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/complications ; Breast Neoplasms/pathology ; Febrile Neutropenia/epidemiology ; Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; In Situ Hybridization, Fluorescence ; Japan ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women.
Autorzy :
Kawada K; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan. .
Mizoo T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Suzuki Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Kajiwara Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Hatono M; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Tsukioki T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Kochi M; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Abe Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Nishiyama K; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Iwamoto T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Ikeda H; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Doihara H; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Ishihara S; Department of Radiology, Okayama Saiseikai General Hospital, 1-17-18 Ifuku-cho, Kitaku, Okayama, 700-8511, Japan.
Kawai H; Department of Breast Surgery, Okayama Rosai Hospital, 1-10-25 Chikkomidori-machi, Minamiku, Okayama, 702-8055, Japan.
Kawasaki K; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, 7-33 Moto-machi, Nakaku, Hiroshima, 730-8518, Japan.
Ishibe Y; Department of Breast Surgery, Mizushima Kyodo Hospital, 1-1 Mizushima minamikasuga-cho, Kurashiki, Okayama, 712-8567, Japan.
Ogasawara Y; Department of Breast Endocrine Surgery, Kagawa Prefecture Central Hospital, 1-2-1 Asahi-machi, Takamatsu, Kagawa, 760-8557, Japan.
Toyooka S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2021 Mar; Vol. 28 (2), pp. 478-487. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
Autorzy :
Takashima T; Osaka City University Graduate School of Medicine, Osaka, Japan.
Hara F; Cancer Institute Hospital of JFCR, Tokyo, Japan.
Iwamoto T; Okayama University Hospital, Okayama, Japan. Electronic address: .
Uemura Y; National Center for Global Health and Medicine, Tokyo, Japan.
Ohsumi S; NHO Shikoku Cancer Center, Matsuyama, Japan.
Yotsumoto D; Sagara Hospital Miyazaki, Social Medical Corporation Miyazaki Hakuaikai, Miyazaki, Japan.
Hozumi Y; University of Tsukuba Hospital, Tsukuba/Ibaraki Prefectural Central Hospital, Kasama, Japan.
Watanabe T; NHO Sendai Medical Center, Sendai, Japan.
Saito T; Japanese Red Cross Saitama Hospital, Saitama, Japan.
Watanabe KI; NHO Hokkaido Cancer Center, Hokkaido, Japan.
Tsurutani J; Showa University, Tokyo, Japan.
Toyama T; Nagoya City University Hospital, Nagoya, Japan.
Akabane H; Hokkaido P.W.F.A.C. Asahikawa-Kosei General Hospital, Asahikawa, Japan.
Nishimura R; Kumamoto Shinto General Hospital, Kumamoto, Japan.
Taira N; Okayama University Hospital, Okayama, Japan.
Ohashi Y; Chuo University, Tokyo, Japan.
Mukai H; National Cancer Center Hospital East, Kashiwa, Japan.
Pokaż więcej
Źródło :
Clinical breast cancer [Clin Breast Cancer] 2021 Feb 01. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer.
Autorzy :
Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan. Electronic address: .
Hara F; Department of Breast Medical Oncology, Cancer Institute Hospital of JFCR, Koto, Tokyo, Japan.
Kitada M; Department of Breast Disease Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
Takahashi M; NHO Hokkaido Cancer Center, Sapporo, Japan.
Kikawa Y; Department of Breast Surgery, Kobe City Medical Center General Hospital, Kobe, Japan.
Kato H; Teine Keijinkai Hospital, Sapporo, Japan.
Sakata E; Niigata City General Hospital, Niigata, Japan.
Naito Y; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Hirosaki, Japan.
Saito T; Japanese Red Cross Saitama Hospital, Saitama, Japan.
Iwasa T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Taira N; Okayama University Hospital, Okayama, Japan.
Takashima T; Osaka City University Graduate School of Medicine, Osaka, Japan.
Kashiwabara K; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Aihara T; Breast Center, Aihara Hospital, Minoh, Japan.
Mukai H; National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Pokaż więcej
Źródło :
Breast (Edinburgh, Scotland) [Breast] 2021 Feb; Vol. 55, pp. 63-68. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Autorzy :
Hatono M; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Ikeda H; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .
Suzuki Y; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Kajiwara Y; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Kawada K; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Tsukioki T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Kochi M; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Suzawa K; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Iwamoto T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Yamamoto H; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Shien T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Yamane M; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Taira N; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Doihara H; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Toyooka S; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jan; Vol. 185 (2), pp. 307-316. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/drug therapy
Isoflavones*/pharmacology
Equol ; Humans ; Neoplasm Recurrence, Local ; Tamoxifen/pharmacology ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan.
Autorzy :
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. .
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kumamaru H; Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Miyata H; Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nakayama K; Department of Breast and Endocrine Surgery, National Center for Global Health and Medicine, Tokyo, Japan.
Shimizu C; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Miyashita M; Department of Gerontological and Oncology Nursing, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Honma N; Department of Pathology, Toho University Faculty of Medicine, Tokyo, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima, Japan.
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2021 Jan; Vol. 28 (1), pp. 1-8. Date of Electronic Publication: 2020 Nov 21.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*analysis
Breast/*pathology
Breast Neoplasms/*mortality
Breast Neoplasms, Male/*mortality
Neoplasm Recurrence, Local/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Breast/surgery ; Breast Neoplasms/diagnosis ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Breast Neoplasms, Male/diagnosis ; Breast Neoplasms, Male/pathology ; Breast Neoplasms, Male/therapy ; Cause of Death ; Chemoradiotherapy, Adjuvant/methods ; Chemoradiotherapy, Adjuvant/statistics & numerical data ; Disease-Free Survival ; Female ; Humans ; Japan/epidemiology ; Male ; Mastectomy, Segmental/statistics & numerical data ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2/analysis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/analysis ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/analysis ; Receptors, Progesterone/metabolism ; Registries/statistics & numerical data ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
Autorzy :
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Uemura Y; Biostatistics Section, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Saito T; Department of Surgery, Japanese Red Cross Saitama Hospital, Saitama, Japan.
Baba S; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Kobayashi K; Department of Medical Oncology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Kawashima H; Department of Surgery, Aomori City Hospital, Aomori, Japan.
Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Sagawa N; Department of Breast Surgery, Kameda Medical Center, Kamogawa, Japan.
Bando H; Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
Yamaguchi M; Department of Breast Surgery, JCHO Kurume General Hospital, Kurume, Japan.
Takashima T; Department of Breast and Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka Japan.
Kashiwaba M; Department of Surgery, Sagara Hospital, Kagoshima, Japan.
Mizuno T; Department of Medical Oncology, Mie University Hospital, Tsu, Japan.
Yamamoto Y; Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Kawahara T; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Mukai H; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Pokaż więcej
Corporate Authors :
RESPECT study group
Źródło :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Nov 10; Vol. 38 (32), pp. 3743-3752. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*metabolism
Trastuzumab/*therapeutic use
Age Factors ; Aged ; Aged, 80 and over ; Breast Neoplasms/enzymology ; Breast Neoplasms/pathology ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Docetaxel/administration & dosage ; Doxorubicin/administration & dosage ; Epirubicin/administration & dosage ; Female ; Humans ; Neoplasm Staging ; Quality of Life ; Survival Rate ; Trastuzumab/administration & dosage
Czasopismo naukowe
Tytuł :
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.
Autorzy :
Hagiwara Y; Department of Biostatistics, Division of Health Sciences and Nursing, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. .
Shiroiwa T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
Taira N; Breast and Endocrine Surgery Department, Okayama University Hospital, Okayama, Japan.
Kawahara T; Clinical Research Promotion Center, The University of Tokyo Hospital, Tokyo, Japan.
Konomura K; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
Noto S; Center for Health Economics and QOL Research, Niigata University of Health and Welfare, Niigata, Japan.
Fukuda T; Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Wako, Japan.
Shimozuma K; Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
Pokaż więcej
Źródło :
Health and quality of life outcomes [Health Qual Life Outcomes] 2020 Nov 03; Vol. 18 (1), pp. 354. Date of Electronic Publication: 2020 Nov 03.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Quality of Life*
Neoplasms/*psychology
Surveys and Questionnaires/*standards
Adult ; Aged ; Algorithms ; Female ; Humans ; Japan ; Logistic Models ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Evaluation of Prognosis of Juvenile Differentiated Thyroid Carcinoma.
Autorzy :
Tsukioki T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Ohtani Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Fujihara M; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Suzuki Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Kajihara Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Hatono M; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Kawada K; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Kochi M; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Iwamoto T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Ikeda H; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Doihara H; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Pokaż więcej
Źródło :
Acta medica Okayama [Acta Med Okayama] 2020 Oct; Vol. 74 (5), pp. 401-406.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Lymphatic Metastasis/*pathology
Neoplasm Recurrence, Local/*pathology
Thyroid Cancer, Papillary/*pathology
Adenocarcinoma/therapy ; Adolescent ; Adult ; Child ; Female ; Humans ; Iodine Radioisotopes/therapeutic use ; Lymphatic Metastasis/diagnostic imaging ; Lymphatic Metastasis/therapy ; Male ; Neoplasm Recurrence, Local/therapy ; Proportional Hazards Models ; Retrospective Studies ; Thyroid Cancer, Papillary/therapy ; Young Adult
Czasopismo naukowe
Tytuł :
Desmoid-type fibromatosis of the breast mimicking cancer.
Autorzy :
Otani Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Doihara H; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama 700-8558, Japan.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Sep 05; Vol. 50 (9), pp. 1084-1085.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower sensitivity to initial ETs.
Autorzy :
Iwamoto T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. .
Fujisawa T; Department of Breast Oncology, Gunma Prefectural Cancer Center, Gunma, Japan.
Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Araki K; Department of Medical Oncology, Gunma Prefectural Cancer Center, Gunma, Japan.
Sakamaki K; Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sangai T; Department of Breast and Thyroid Surgery, Chiba University Hospital, Chiba, Japan.
Kikawa Y; Department of Breast Surgery, Kobe City Medical Center General Hospital, Kobe, Japan.
Takao S; Department of Breast Surgery, Hyogo Cancer Center, Hyogo, Japan.
Nishimura R; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
Aihara T; Breast Center, Aihara Hospital, Osaka, Japan.
Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Pokaż więcej
Źródło :
Breast cancer (Tokyo, Japan) [Breast Cancer] 2020 Sep; Vol. 27 (5), pp. 973-981. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Postmenopause*
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Breast Neoplasms/*drug therapy
Receptors, Estrogen/*antagonists & inhibitors
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Aromatase Inhibitors/pharmacology ; Aromatase Inhibitors/therapeutic use ; Breast/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Estrogen Receptor Modulators/pharmacology ; Estrogen Receptor Modulators/therapeutic use ; Everolimus/pharmacology ; Everolimus/therapeutic use ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Progression-Free Survival ; Prospective Studies ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism
Czasopismo naukowe
Tytuł :
Influences of preoperative metformin on immunological factors in early breast cancer.
Autorzy :
Tsukioki T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Shien T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan. .
Tanaka T; Department of Pathology, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Suzuki Y; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Kajihara Y; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Hatono M; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Kawada K; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Kochi M; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Iwamoto T; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Ikeda H; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Taira N; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Doihara H; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Toyooka S; Department of General Thoracic Surgery and Breast and Endocrine Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 7008558, Japan.
Pokaż więcej
Źródło :
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Jul; Vol. 86 (1), pp. 55-63. Date of Electronic Publication: 2020 Jun 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Preoperative Care*
Breast Neoplasms/*immunology
Breast Neoplasms/*surgery
Metformin/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; B7-H1 Antigen/metabolism ; Biopsy, Large-Core Needle ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; CD4-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/drug effects ; Female ; Humans ; Immunologic Factors/metabolism ; Interleukin-2/metabolism ; Lymphocytes, Tumor-Infiltrating/drug effects ; Metformin/administration & dosage ; Middle Aged ; Prospective Studies ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
Response Shift-Adjusted Treatment Effect on Health-Related Quality of Life in a Randomized Controlled Trial of Taxane Versus S-1 for Metastatic Breast Cancer: Structural Equation Modeling.
Autorzy :
Murata T; Department of Oral Implantology, Osaka Dental University, Hirakata, Japan; CRECON Medical Assessment, Inc, Tokyo, Japan. Electronic address: .
Suzukamo Y; Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shiroiwa T; Department of Health and Welfare Services, National Institute of Public Health, Saitama, Japan.
Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Shimozuma K; Department of Biomedical Sciences, Ritsumeikan University, Kusatsu, Shiga, Japan.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Jun; Vol. 23 (6), pp. 768-774. Date of Electronic Publication: 2020 May 17.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Antineoplastic Agents/*administration & dosage
Breast Neoplasms/*drug therapy
Oxonic Acid/*administration & dosage
Taxoids/*administration & dosage
Tegafur/*administration & dosage
Adult ; Aged ; Drug Combinations ; Female ; Humans ; Latent Class Analysis ; Middle Aged ; Reproducibility of Results ; Surveys and Questionnaires
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies